$256,404,564

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

biotechexpiring · 16d· period of performance ends in 16 days

ACTION DATE2026-04-13·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50119C00075_7505_-NONE-_-NONE-

Award description

BOTULISM ANTITOXIN

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Procurement of botulism antitoxin for emergency preparedness and public health response capabilities.

Sub-sectors

medical-countermeasuresemergency-preparednessbiologics

Why this matters

Botulism antitoxin is a critical medical countermeasure for biodefense and public health emergencies, essential for rapid response to biological threats.

Supply-chain signal

Large-scale procurement signals increased demand for specialized biologic manufacturing capacity and cold-chain distribution infrastructure for emergency medical countermeasures.

U.S.–China competition angle

Securing domestic production of critical medical countermeasures reduces reliance on foreign suppliers and strengthens U.S. biodefense independence.

Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-14. Cost: $0.001436.

Period of performance

Start

2019-09-30

End

2026-05-31

Status

expiring · 16din 16 days

Sources

Award record ingested from usaspending. Source identifier CONT_AWD_75A50119C00075_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.